B-Line Medical Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • B-Line Medical's estimated annual revenue is currently $19.4M per year.(i)
  • B-Line Medical's estimated revenue per employee is $145,000

Employee Data

  • B-Line Medical has 134 Employees.(i)

B-Line Medical's People

NameTitleEmail/Phone
1
Co-FounderReveal Email/Phone
2
Director, Human Resources and OperationsReveal Email/Phone
3
Sales ConsultantReveal Email/Phone
4
Product Support AnalystReveal Email/Phone
5
Principal ConsultantReveal Email/Phone
6
Technical Sales ConsultantReveal Email/Phone
7
Financial AccountantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.4M24N/AN/AN/A
#2
$5.1M447%N/AN/A
#3
$0.5M15-6%$265MN/A
#4
$1M129%N/AN/A
#5
$1.4M167%N/AN/A
#6
$0.6M8-53%N/AN/A
#7
$1.5M176%N/AN/A
#8
$14.5M1005%N/AN/A
#9
$16.7M1156%N/AN/A
#10
$1.4M16N/AN/AN/A
Add Company

What Is B-Line Medical?

B-Line Medical is a digital solutions firm that draws upon a decade of experience in developing intuitive internet applications and real-time data handling. B-Line Medical specializes in the delivery of user-centric technical solutions that have helped universities and organizations such as NASA, GSA, Commercial Vehicle Safety Alliance and NEA connect with people.

keywords:N/A

N/A

Total Funding

134

Number of Employees

$19.4M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

B-Line Medical News

2022-04-20 - Promising Responses Observed With Axi-Cel in High-Risk LBCL

Treatment with first-line axicabtagene ciloleucel (axi-cel; ... responses in patients with high-risk large B-cell lymphoma (LBCL),...

2022-04-17 - B-1 Bomber Catches Fire on Flight Line at Dyess

A B-1B bomber caught fire on the flight line at Dyess Air Force Base, ... to a local medical facility with “non-life-threatening injuries,”...

2022-04-13 - Axicabtagene ciloleucel approved for second-line treatment of large B-cell lymphoma

... of large B-cell lymphoma (LBCL) that is refractory to first-line ... of first-line chemotherapy, the U.S. Food and Drug Administration...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$19.4M13429%N/A
#2
$15M1346%N/A
#3
$32.8M134-1%N/A
#4
$43.3M1345%N/A
#5
$15M1342%N/A